Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$58.71 -1.29 (-2.15%)
As of: Oct 1, 2026 · 3:08 PM EDT

Biomarin Pharmaceutical (BMRN) Other Non-Current Liabilities (2009 - 2026)

Updated

Biomarin Pharmaceutical (BMRN) posted Other Non-Current Liabilities of $209.82 million for Q2 2026, up 41.0% from $148.82 million a year earlier and up 35.0% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Biomarin Pharmaceutical's Other Non-Current Liabilities came in at $150.82 million, up 17.1% from FY2024.

  • Annual Other Non-Current Liabilities has increased for four consecutive years, with a five-year compound annual growth rate of 5.7% (FY2020 to FY2025).
  • In prior years, Biomarin Pharmaceutical's Other Non-Current Liabilities was $128.82 million in FY2024 (+7.4%), $119.94 million in FY2023 (+19.9%), $100.02 million in FY2022 (+1.7%) and $98.36 million in FY2021 (-13.9%).
  • The Q2 2026 figure stands as the highest quarterly Other Non-Current Liabilities since Q1 2016.
  • On a year-over-year basis, Other Non-Current Liabilities has increased in each of the last 13 quarters, with growth averaging 21.2% over the last eight quarters.
  • The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was Q2 2026, with growth of 41.0%; the weakest was Q3 2021, with a decline of 14.9%.
  • According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $155.48 million (Q1 2026), $150.82 million (Q4 2025) and $163.06 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Biomarin Pharmaceutical 11.61 Bn 5.48 Bn 786.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 209.82 Mn
Mar 31, 2026 155.48 Mn
Dec 31, 2025 150.82 Mn
Sep 30, 2025 163.06 Mn
Jun 30, 2025 148.82 Mn
Mar 31, 2025 129.69 Mn
Dec 31, 2024 128.82 Mn
Sep 30, 2024 127.51 Mn
Jun 30, 2024 119.37 Mn
Mar 31, 2024 117.35 Mn
Dec 31, 2023 119.94 Mn
Sep 30, 2023 105.46 Mn
Jun 30, 2023 98.12 Mn
Mar 31, 2023 92.42 Mn
Dec 31, 2022 100.02 Mn
Sep 30, 2022 92.47 Mn
Jun 30, 2022 95.26 Mn
Mar 31, 2022 100.91 Mn
Dec 31, 2021 98.36 Mn
Sep 30, 2021 103.13 Mn
API Access

Biomarin Pharmaceutical Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BMRN&period=max&api_key=YOUR_API_KEY